CD8A and neoplasm: Engineered HEK293T-derived sEVs (mVSVG-Exo) stimulated DCs through a TLR4-dependent manner, leading to the activation of CD8+ T-cells and CD4+ T-cells of tumor-draining lymph nodes in a lymphoma mouse model.